Ningxia Qiyuan Pharmaceutical Co., Ltd., established in January 2001, emerged from the restructuring of the Ningxia Pharmaceutical Factory and Ningxia Traditional Chinese Medicine Factory. It is a leading biopharmaceutical enterprise focused on the R&D, manufacturing, and sales of Active Pharmaceutical Ingredients (APIs), including Erythromycin, Tetracycline, Vitamin C, and other related products. The company has a strong reputation for quality and technological innovation, exporting its products to markets across Europe, the Americas, Asia, and Africa.